Press Release

Myomo Hosts NYSE MKT IPO Investor Webinar on March 28, 2017

March 28, 2017

Myomo, Inc., (“Myomo” or the “Company”), a commercial stage medical robotics company, announced today that it is hosting a live, interactive webinar of the Company’s $15 million Reg A+ IPO investment opportunity, followed by a Q&A with Myomo CEO, Paul R. Gudonis. The investor webinar will take place on Tuesday, March 28th at 2:00pm EDT.

Myomo's investor webinar will include discussion on the Company's plans for growth as well as its non-invasive technology, exclusively licensed from Massachusetts Institute of Technology, which restores a patient’s ability to use their partially paralyzed or weakened arms and hands again so they can return to work, live independently and reduce their cost of care. Due to the large number of strokes, spinal cord injuries, and other neurological conditions that occur each year, the MyoPro® has the capability to help millions of individuals worldwide.

“We are very excited to share our vision of restoring upper limb to the large number of individuals impacted by paralysis with a broad set of individual investors that now have the opportunity to invest in our Company, alongside accredited investors and institutions, at our initial offering price,” said Mr. Gudonis. “While a traditional public offering is generally reserved for large institutions and the Wall Street elite to invest at this stage, we are taking advantage of new SEC regulations to level the playing field for all investors to participate concurrently in our IPO.”

The Company seeks to raise up to $15 million in its IPO under Regulation A+ and then, in succession and subject to NYSE requirements, be listed on the NYSE MKT as “MYO.” TriPoint Global Equities, LLC, working with its online division BANQ® (www.banq.co), will act as the lead managing selling agent and bookrunner for the offering. Myomo intends to use the proceeds from the offering to fund sales and marketing, product development, repayment of debt, and for working capital and other general corporate purposes. To learn more about the IPO or to invest visit www.banq.co/listings/myomo

To register for the webinar, please visit http://events.shindig.com/event/tripointmyomo.

About Myomo, Inc.

Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.

Myomo Inc.’s offering statement for its initial public offering under Regulation A has been qualified by the Securities and Exchange Commission. The securities offered by Myomo Inc. are highly speculative. Investing in shares of Myomo Inc. involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops following the offering, it may not continue. To obtain a copy of the Offering Circular, go to Myomo Form 1-A at https://goo.gl/z7npq1.

Forward-Looking Statements

This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the Company, expressed by such language as “expected,” “anticipated,” “projected” and “forecasted.” Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the Company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.

About BANQ

Made in New York, BANQ® is a division of TriPoint Global Equities, LLC. Member FINRA | SIPC Check the background of this firm on FINRA’s Broker Check. Business Continuity Plan

Contact Details

917 512 0825
sales@tpglobal.com
1450 Broadway, 26th Floor New York, NY 10018

Contact us
BANQ.CO IS THE ONLINE DIVISION AND WEBSITE OPERATED BY TRIPOINT GLOBAL EQUITIES LLC, A REGISTERED BROKER/DEALER AND MEMBER FINRA/SIPC. ALL SECURITIES ARE OFFERED BY TRIPOINT GLOBAL EQUITIES. BY ACCESSING THIS SITE AND ANY PAGES THEREOF, YOU AGREE TO BE BOUND BY ITS TERMS OF USE AND PRIVACY POLICY. COMPANY LISTINGS ON THIS SITE ARE ONLY SUITABLE FOR INVESTORS WHO ARE FAMILIAR WITH AND WILLING TO ACCEPT THE HIGH RISK ASSOCIATED WITH HIS OR HER RISK INVESTMENTS. SECURITIES SOLD THROUGH PRIVATE PLACEMENTS ARE NOT PUBLICLY TRADED AND ARE INTENDED FOR INVESTORS WHO DO NOT HAVE A NEED FOR A LIQUID INVESTMENT. THERE CAN BE NO ASSURANCE THE COMPANY’S VALUATION IS ACCURATE OR IN AGREEMENT WITH THE MARKET OR INDUSTRY VALUATIONS. ADDITIONALLY, INVESTORS MAY RECEIVE RESTRICTED STOCK THAT MAY BE SUBJECT TO HOLDING PERIOD REQUIREMENTS. COMPANIES SEEKING PRIVATE PLACEMENT INVESTMENTS TEND TO BE IN AN EARLIER STAGE OF DEVELOPMENT AND HAVE NOT YET BEEN FULLY TESTED IN THE PUBLIC MARKETPLACE. INVESTING IN PRIVATE PLACEMENTS REQUIRES HIGH RISK TOLERANCE, LOW LIQUIDITY CONCERNS, AND LONG-TERM COMMITMENTS. INVESTORS MUST BE ABLE TO AFFORD TO LOSE THEIR ENTIRE INVESTMENT. IN ADDITION, REGULATION A OFFERINGS WILL BE MADE ONLY BY MEANS OF AN OFFERING STATEMENT ON FORM 1-A WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION ONCE QUALIFIED. NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED IN CONNECTION WITH THE INFORMATION PROVIDED, AND, IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT ON FORM 1-A HAS BEEN FILED AND UNTIL THE OFFERING STATEMENT IS QUALIFIED PURSUANT TO REGULATION A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ITS ACCEPTANCE IS GIVEN AFTER THE QUALIFICATION DATE. THE SECURITIES OFFERED USING REGULATION A ARE HIGHLY SPECULATIVE AND INVOLVE SIGNIFICANT RISKS. THE INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES, AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THE OFFERING, IT MAY NOT CONTINUE. SOME ISSUERS MAY INTEND TO LIST ITS SECURITIES ON A NATIONAL EXCHANGE AND DOING SO ENTAILS SIGNIFICANT ONGOING CORPORATE OBLIGATIONS INCLUDING, BUT NOT LIMITED TO, DISCLOSURE, FILING AND NOTIFICATION REQUIREMENTS, AS WELL COMPLIANCE WITH APPLICABLE CONTINUED QUANTITATIVE AND QUALITATIVE LISTING STANDARDS.


Copyright © TriPoint Global Equities, LLC.